OCT 31, 2018 09:02 AM PDT

Cytostatic Drug Proved Potent For Cancer

WRITTEN BY: Nouran Amin

Image via ArcoMed

A study published in journal Angewandte Chemie, describes how a cytostatic drug, consisting of therapeutically active molecules that is linked to specific antibodies can treat tumors. Such novel conjugates are made from antibodies and a protein that inhibits kinesin spindle formation.

The study revealed that changing the “linkage” between these two components allows for the drugs cytostatic activity in a broad palette of cancers.

The purpose of the study was to introduce a new cytostatic drug that will not produce adverse effects on cancer patients. This is especially true since many medications may be effective but interfere with physiological regulatory mechanisms that cause the impairment of immune defenses, produce hair loss, and induce nausea.

Watch the short video below on side-effects of chemotherapeutic drugs:

The study was aimed at introducing a cytostatic drug directly into tumor cells before triggering a toxic effect. One proposed way was to attach small drug molecules to an antibody (that binds to specific sites—antigens) and produce a conjugate.

The linker will serve as a bridging component that will hold the conjugate together for as long as it circulates in the blood. Although incorporating cytostatic drugs into antibody conjugates have been so far successful, they are limited.

Diverging away from the classic mechanisms of cytostatic drugs, researchers have opted to use cytotoxin that which that utilizes a different biological pathway. More specifically, the cytotoxin is a novel pyrrole-based kinesin spindle protein (KSP) inhibitor which is implicated centrosome separation during cell division. Low doses of this cytoxin is highly effective enough to inhibiting this step of the cell cycle leading to a strong antitumor effect. The researchers have demonstrated that use of this technique can produce a highly effective antibody conjugates that allow them to target a variety of tumor types.

Image Credit: Wiley Online Libraries

The developed conjugates were seen to be very potent in vitro and when using experiments on mice, the conjugates led to complete remission of a human bladder tumor model with minimal side effects

Source: Wiley

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
Treating Drug-Resistant Acute Lymphoblastic Leukemia
New therapeutics may have helped improve survival rates for acute lymphoblastic leukemia patients but some patients still remain unresponsive to existing t...
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
Does Modafinil Really Increase Brain Function?
Modafinil, often sold under the name “Provigil”, is a wakefulness-promoting drug used to treat excessive sleeping in conditions such as narcole...
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
A Diabetic Drug that Promotes Brain Repair...But it Only Works in Females
Gender discrimination in research has long stopped serious advancements. In neuroscience, scientists believed that male brains are straightforward and do n...
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
Injectable Drug reverses symptoms of liver disease in people with HIV
In a study conducted by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Cancer Institute, scientists report that an inje...
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
Therapeutic To Treat The Detrimental Effects of Marijuana
As U.S. states continue to legalize the use of marijuana, so is the number of American women using cannabis before becoming pregnant and to treat morning s...
OCT 23, 2019
Cancer
OCT 23, 2019
An alternative for immunotherapy-resistant cancer patients
A twist to traditional immunotherapies could help cancer patients’ immune systems better detect cancer cells, making this new system capable of targe...
Loading Comments...